[Cambendazole: new anthelmintic in the therapy of strongyloidiasis. Clinical trial].
D000293:Adolescent; D001562:Benzimidazoles / Q000627:therapeutic use*; D002159:Cambendazole / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D013322:Strongyloidiasis / Q000188:drug therapy*
D001562:Benzimidazoles; D002159:Cambendazole
Cambendazol: novo anti-helmíntico na terapêutica da estrongiloidíase. Experimentação clínica.